315 related articles for article (PubMed ID: 929152)
1. [Frequent cases of agranulocytosis due to clozapin (leponex) in eastern Switzerland].
Jungi WF; Fischer J; Senn HJ; Hartlapp J; Pöldinger W; Kunz H; Krupp P
Schweiz Med Wochenschr; 1977 Dec; 107(49):1861-4. PubMed ID: 929152
[TBL] [Abstract][Full Text] [Related]
2. Agranulocytosis in patients treated with clozapine. A study of the Finnish epidemic.
Amsler HA; Teerenhovi L; Barth E; Harjula K; Vuopio P
Acta Psychiatr Scand; 1977 Oct; 56(4):241-8. PubMed ID: 920225
[TBL] [Abstract][Full Text] [Related]
3. Blood dyscrasias in clozapine-treated patients in Italy.
Lambertenghi Deliliers G
Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
[TBL] [Abstract][Full Text] [Related]
4. Clozapine treatment after agranulocytosis induced by classic neuroleptics.
Bauer M; Mackert A
J Clin Psychopharmacol; 1994 Feb; 14(1):71-3. PubMed ID: 7908676
[TBL] [Abstract][Full Text] [Related]
5. [Clozapine: an exclusive treatment?].
Vanelle JM
Encephale; 1992 Sep; 18 Spec No 3():441-5. PubMed ID: 1339761
[TBL] [Abstract][Full Text] [Related]
6. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
Hägg S; Rosenius S; Spigset O
Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
[TBL] [Abstract][Full Text] [Related]
7. [Clozapine (Leponex)].
Bilikiewicz A; Sulestrowska H
Psychiatr Pol; 1977; 11(2):251-3. PubMed ID: 887685
[No Abstract] [Full Text] [Related]
8. [Problem of side effects of leponex on blood (multicenter inter- national study)].
Panteleeva GP; Gamkrelidze ShA; Dikaia VI; Magalif AA; Okuneva TP; Perevozniuk AG; Shtemberg K; Filip V; German E; Zapletanek M
Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(10):70-3. PubMed ID: 1665659
[TBL] [Abstract][Full Text] [Related]
9. [Hematological complications caused by clozapine (Leponex)].
Palva I
Duodecim; 1976; 92(1):1-2. PubMed ID: 1248428
[No Abstract] [Full Text] [Related]
10. Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs.
Lieberman JA; Johns CA; Kane JM; Rai K; Pisciotta AV; Saltz BL; Howard A
J Clin Psychiatry; 1988 Jul; 49(7):271-7. PubMed ID: 3391979
[TBL] [Abstract][Full Text] [Related]
11. Agranulocytosis during treatment with chlozapine.
Idänpään-Heikkilä J; Alhava E; Olkinuora M; Palva IP
Eur J Clin Pharmacol; 1977 Mar; 11(3):193-8. PubMed ID: 856603
[TBL] [Abstract][Full Text] [Related]
12. Clozapine for refractory schizophrenia: an open study of 14 patients treated up to 2 years.
Mattes JA
J Clin Psychiatry; 1989 Oct; 50(10):389-91. PubMed ID: 2571612
[TBL] [Abstract][Full Text] [Related]
13. Clozapine-associated agranulocytosis: risk and aetiology.
Krupp P; Barnes P
Br J Psychiatry Suppl; 1992 May; (17):38-40. PubMed ID: 1418887
[TBL] [Abstract][Full Text] [Related]
14. Double-blind comparison of clozapine with chlorpromazine in acute schizophrenic illness.
Chiu E; Burrows G; Stevenson J
Aust N Z J Psychiatry; 1976 Dec; 10(4):343-7. PubMed ID: 798582
[TBL] [Abstract][Full Text] [Related]
15. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
Meged S; Stein D; Sitrota P; Melamed Y; Elizur A; Shmuelian I; Gazit E
Int Clin Psychopharmacol; 1999 Sep; 14(5):305-12. PubMed ID: 10529073
[TBL] [Abstract][Full Text] [Related]
16. Clozapine-induced agranulocytosis: a situation report up to August 1976.
Anderman B; Griffith RW
Eur J Clin Pharmacol; 1977 Mar; 11(3):199-201. PubMed ID: 852497
[TBL] [Abstract][Full Text] [Related]
17. [Hematologic effects of clozapine: evaluation of the international experience].
Lamarque V
Encephale; 1995 Jun; 21 Spec No 3():59-60. PubMed ID: 7628344
[TBL] [Abstract][Full Text] [Related]
18. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.
Alvir JM; Lieberman JA; Safferman AZ; Schwimmer JL; Schaaf JA
N Engl J Med; 1993 Jul; 329(3):162-7. PubMed ID: 8515788
[TBL] [Abstract][Full Text] [Related]
19. Clozapine and agranulocytosis.
Senn HJ; Jungi WF; Kunz H; Pöldinger W
Lancet; 1977 Mar; 1(8010):547. PubMed ID: 65644
[No Abstract] [Full Text] [Related]
20. Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?
Levin H; Chengappa KN; Kambhampati RK; Mahdavi N; Ganguli R
J Clin Psychiatry; 1992 Jul; 53(7):248-51. PubMed ID: 1353492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
